Orchard Therapeutics plc Quarterly Liabilities, Current in USD from Q4 2017 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Orchard Therapeutics plc quarterly Liabilities, Current history and growth rate from Q4 2017 to Q3 2023.
Orchard Therapeutics plc Liabilities, Current for the quarter ending September 30, 2023 was $49.4M, a 1.77% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$49.4M	-$890K	-1.77%	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$57.5M	+$9.11M	+18.8%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$53.3M	+$6.38M	+13.6%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$60.6M	+$17.8M	+41.5%	Dec 31, 2022	10-Q	2023-11-13
Q3 2022	$50.3M	+$6.02M	+13.6%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$48.4M	+$7.45M	+18.2%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$46.9M	-$1.57M	-3.25%	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$42.8M	-$8.77M	-17%	Dec 31, 2021	10-K	2023-03-14
Q3 2021	$44.2M	+$3.48M	+8.54%	Sep 30, 2021	10-Q	2021-11-04
Q2 2021	$41M	-$1.07M	-2.54%	Jun 30, 2021	10-Q	2021-08-04
Q1 2021	$48.5M	+$3.68M	+8.22%	Mar 31, 2021	10-Q	2021-05-13
Q4 2020	$51.6M	-$4.3M	-7.69%	Dec 31, 2020	10-K	2022-03-30
Q3 2020	$40.8M	-$3.54M	-8%	Sep 30, 2020	10-Q	2020-11-03
Q2 2020	$42M	-$13.4M	-24.2%	Jun 30, 2020	10-Q	2020-08-06
Q1 2020	$44.8M	+$10.1M	+29.1%	Mar 31, 2020	10-Q	2020-05-07
Q4 2019	$55.9M	+$7.95M	+16.6%	Dec 31, 2019	10-K	2021-03-02
Q3 2019	$44.3M			Sep 30, 2019	6-K	2019-11-07
Q2 2019	$55.4M			Jun 30, 2019	6-K	2019-08-08
Q1 2019	$34.7M			Mar 31, 2019	6-K	2019-05-28
Q4 2018	$47.9M	+$37.2M	+345%	Dec 31, 2018	10-K	2020-02-27
Q4 2017	$10.8M			Dec 31, 2017	20-F	2019-03-22

Showing 1 to 21 of 21 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.